Nalfon (fenoprofen) is a small molecule pharmaceutical. Fenoprofen was first approved as Nalfon on 1982-01-01. It is used to treat osteoarthritis, pain, and rheumatoid arthritis in the USA. The pharmaceutical is active against prostaglandin G/H synthase 1. In addition, it is known to target sodium-coupled monocarboxylate transporter 1.
|Indication||osteoarthritis, pain, rheumatoid arthritis|
|Drug Class||Anti-inflammatory/analgesic agents (ibuprofen type)|